NielsenIQ BASES Announces The 2022 Design Impact Award Winners
NielsenIQ is pleased to announce the 2022 recipients of the seventh annual NielsenIQ BASES Design Impact Awards for the consumer-packaged goods (CPG) industry. The global competition recognizes and celebrates best-in-class package redesigns, and the business impacts they make for their companies. This year’s winners include brands that delivered innovative and creative packaging with design concepts that reflected brand vision while supporting the shopper journey.
Sixty brands submitted package redesigns and the NielsenIQ BASES team used the company’s proprietary Retail Measurement Sales (RMS) data to identify which brands demonstrated an increase in sales after the launch of the updated package designs. In addition to evaluating RMS data, NielsenIQ conducted a behavioral survey of 15,000 shoppers to assess individual entries across the shopper journey. Each product was evaluated to determine if it presented a visually appealing, easily identifiable package that allowed consumers to find the product on shelves and engage them to purchase the item. The results unveiled 10 winners across various CPG categories with excellent designs and a measurable increase in sales.
“Our team is thrilled to support and promote inspired brands who deliver fresh, beautifully designed packages that stimulate brand growth and financial successes,” said Andrea Fraboni, Vice President & Global Leader of BASES Design Solutions at NielsenIQ. “This year’s winners embody how effective redesigned packaging can help transform and elevate the bottom line of a brand. These companies did it right and we’re excited to showcase their outstanding accomplishments.”
The winners of the 2022 NielsenIQ BASES Design Impact Award* are:
- L’usine Sliced Multigrain Bread (Parent Company: Almarai; Country: Saudi Arabia)
- Coors Light Beer (Parent Company: Molson Coors Beverage Company; Design Agency: Soulsight; Country: United States)
- Brooke's Oros Beverages (Parent Company: Tiger Brands; Design Agency: Just Design; Country: South Africa)
- Cadbury Old Gold Chocolate (Parent Company: Mondelez International; Design Agency: Bulletproof; Country: Australia)
- Lucozade Energy Drink (Parent Company: Suntory; Country: United Kingdom)
- Nescafé Artesano Coffee (Parent Company: Nestlé; Country: Colombia)
- SSENSE Herbal Tea (Parent Company: SSENSE; Design Agency: Pigeon; Country: Canada)
- Turin Chocolate (Parent Company: Mars; Country: Mexico)
- Speed Stick & Lady Speed Stick (Parent Company: Colgate-Palmolive; Design Agency: Dragon Rouge BZ; Country: Mexico)
- Lay's Potato Chips (Parent Company: PepsiCo; Design Agency: PEP Global Design Team; Country: South Africa)
Learn more about our package design research solutions, the NielsenIQ BASES Design Impact Award, and learnings from this year’s winners by visiting the BASES Design Impact Award web page.
*All products and company names are trademarks of their respective holders. No affiliation or endorsement is expressed or implied.
About NielsenIQ
NielsenIQ, a global information services company, delivers the gold standard in consumer and retail measurement, through the most connected, complete, and actionable understanding of the evolving global, omnichannel consumer. NielsenIQ is the source of confidence for the industries we serve and the pioneer defining the next century of consumer and retail measurement. Our data, connected insights, and predictive analytics optimize the performance of CPG and retail companies, bringing them closer to the communities they serve and helping to power their growth.
NielsenIQ, an Advent International portfolio company, has operations in 90+ markets, covering more than 90% of the world’s population. For more information, visit NielsenIQ.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220721005158/en/
Contact information
Media
Gillian Mosher
Gillian.Mosher@nielseniq.com
647-282-9714
About Business Wire
Business WireSubscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit28.4.2024 13:57:00 CEST | Press release
TUM (Technical University of Munich) from Germany, claimed victory at the inaugural Abu Dhabi Autonomous Racing League (A2RL), at Yas Marina Circuit on Saturday (April 27). As the cars lined up on the grid, with antennae, sensors, AI capabilities, and drive-by-wire systems instead of human drivers, eight teams vied with one another over two days of races and challenges. TUM beat back the competition with its coding and engineering skills in a world-first, four-car race finale, to claim the winner’s share of US$2.25 million prize pot. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428292385/en/ TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit - (Photo: AETOSWire) Bringing a science experiment to the racetrack, the inaugural race pushed the boundaries of autonomous technology while adding entertainment value to extreme sports at an unprecedented scale. A2RL drew over 10,000
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom